Precipio (PRPO) Competitors $5.10 -0.05 (-1.07%) As of 04:00 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock PRPO vs. CLIR, AXDX, DAIO, STAI, ASTC, BNGO, TLIS, TBIO, SMIT, and SPECShould you be buying Precipio stock or one of its competitors? The main competitors of Precipio include ClearSign Technologies (CLIR), Accelerate Diagnostics (AXDX), Data I/O (DAIO), Scantech AI Systems (STAI), Astrotech (ASTC), Bionano Genomics (BNGO), Talis Biomedical (TLIS), Telesis Bio (TBIO), Schmitt Industries (SMIT), and Spectaire (SPEC). These companies are all part of the "measuring and control equipment" industry. Precipio vs. ClearSign Technologies Accelerate Diagnostics Data I/O Scantech AI Systems Astrotech Bionano Genomics Talis Biomedical Telesis Bio Schmitt Industries Spectaire Precipio (NASDAQ:PRPO) and ClearSign Technologies (NASDAQ:CLIR) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, media sentiment, community ranking, earnings, dividends, profitability, analyst recommendations, valuation and risk. Which has more volatility and risk, PRPO or CLIR? Precipio has a beta of 1.37, suggesting that its stock price is 37% more volatile than the S&P 500. Comparatively, ClearSign Technologies has a beta of 1.18, suggesting that its stock price is 18% more volatile than the S&P 500. Do insiders & institutionals believe in PRPO or CLIR? 10.4% of Precipio shares are owned by institutional investors. Comparatively, 24.0% of ClearSign Technologies shares are owned by institutional investors. 13.3% of Precipio shares are owned by company insiders. Comparatively, 16.9% of ClearSign Technologies shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth. Does the media favor PRPO or CLIR? In the previous week, Precipio and Precipio both had 6 articles in the media. ClearSign Technologies' average media sentiment score of 0.90 beat Precipio's score of 0.44 indicating that ClearSign Technologies is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Precipio 1 Very Positive mention(s) 3 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral ClearSign Technologies 1 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Does the MarketBeat Community prefer PRPO or CLIR? Precipio received 120 more outperform votes than ClearSign Technologies when rated by MarketBeat users. Likewise, 73.32% of users gave Precipio an outperform vote while only 41.08% of users gave ClearSign Technologies an outperform vote. CompanyUnderperformOutperformPrecipioOutperform Votes27273.32% Underperform Votes9926.68% ClearSign TechnologiesOutperform Votes15241.08% Underperform Votes21858.92% Which has better earnings & valuation, PRPO or CLIR? ClearSign Technologies has lower revenue, but higher earnings than Precipio. ClearSign Technologies is trading at a lower price-to-earnings ratio than Precipio, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioPrecipio$17.41M0.45-$5.85M-$2.94-1.80ClearSign Technologies$4.28M6.13-$5.19M-$0.11-4.75 Do analysts recommend PRPO or CLIR? ClearSign Technologies has a consensus price target of $6.00, suggesting a potential upside of 1,049.43%. Given ClearSign Technologies' stronger consensus rating and higher possible upside, analysts plainly believe ClearSign Technologies is more favorable than Precipio.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Precipio 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00ClearSign Technologies 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Is PRPO or CLIR more profitable? Precipio has a net margin of -17.23% compared to ClearSign Technologies' net margin of -118.93%. Precipio's return on equity of -34.01% beat ClearSign Technologies' return on equity.Company Net Margins Return on Equity Return on Assets Precipio-17.23% -34.01% -25.27% ClearSign Technologies -118.93%-50.44%-41.41% SummaryClearSign Technologies beats Precipio on 9 of the 17 factors compared between the two stocks. Remove Ads Get Precipio News Delivered to You Automatically Sign up to receive the latest news and ratings for PRPO and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PRPO vs. The Competition Export to ExcelMetricPrecipioAnalytical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$7.83M$4.06B$5.33B$7.13BDividend YieldN/A0.54%4.87%4.05%P/E Ratio-2.8926.4522.8917.40Price / Sales0.454.06357.5184.53Price / CashN/A36.2738.1634.64Price / Book0.521.586.253.79Net Income-$5.85M-$83.57M$3.21B$247.10M7 Day Performance-10.21%-6.79%-8.04%-7.61%1 Month Performance-26.19%-13.25%-2.99%-10.32%1 Year Performance-16.38%-39.15%3.54%-7.75% Precipio Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PRPOPrecipio0.5742 of 5 stars$5.27+2.3%N/A-18.4%$7.81M$17.41M-2.8860Short Interest ↑CLIRClearSign Technologies2.5202 of 5 stars$0.77-1.1%$6.00+683.0%-38.6%$38.49M$4.28M-6.9710Earnings ReportAnalyst ForecastGap DownAXDXAccelerate Diagnostics1.4846 of 5 stars$1.04-1.9%$1.00-3.8%-23.2%$26.05M$11.91M-0.36220Analyst ForecastGap DownHigh Trading VolumeDAIOData I/O1.676 of 5 stars$2.47-1.4%$4.00+62.3%-30.5%$22.77M$21.77M-12.97100STAIScantech AI SystemsN/A$2.61-7.1%N/AN/A$11.68M$522,166.000.00N/APositive NewsGap UpASTCAstrotech1.0053 of 5 stars$6.40-1.4%N/A-27.7%$10.89M$419,000.00-0.7810BNGOBionano Genomics1.3114 of 5 stars$3.30+1.5%$90.00+2,627.3%-94.5%$8.88M$33.33M-0.02300Analyst ForecastGap DownTLISTalis BiomedicalN/A$1.74+8.1%N/A-81.5%$3.17M$300,000.00-0.06260TBIOTelesis BioN/A$0.39flatN/A-96.7%$703,000.00$225.09M-0.01200SMITSchmitt IndustriesN/A$0.02flatN/A-39.3%$69,000.00$9.89M0.00160SPECSpectaireN/A$0.00-9.1%N/A-99.9%$18,000.00N/A0.008 Remove Ads Related Companies and Tools Related Companies ClearSign Technologies Alternatives Accelerate Diagnostics Alternatives Data I/O Alternatives Scantech AI Systems Alternatives Astrotech Alternatives Bionano Genomics Alternatives Talis Biomedical Alternatives Telesis Bio Alternatives Schmitt Industries Alternatives Spectaire Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:PRPO) was last updated on 4/4/2025 by MarketBeat.com Staff From Our PartnersHere’s How to Claim Your Stake in Elon’s Private Company, xAIEven though xAI is a private company, tech legend and angel investor Jeff Brown found a way for everyday folks...Brownstone Research | SponsoredDOGE Social Security bombshell?Elon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredDOGE could send 6 AI stocks through the roofStay alert for Elon Musk and the Department of Government Efficiency's next move … Expect an announcement f...Weiss Ratings | SponsoredYour Retirement Is Caught in the CrossfireWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredTrump’s Final Plan Presidential insider exposes shocking plot to reshape U.S. economy: The 2025 Trump Reset -- Inside Trump’...Porter & Company | SponsoredWall St. Icon: Looming Financial Tsunami Could Wipe Out the 1%Wall Street icon who forecasted Black Monday and dot-com crash says a new economic event could hit the America...InvestorPlace | SponsoredControversial opinion: Volume isn't enough.Don’t be fooled by volume alone — it's just one piece of the trading puzzle. High demand doesn’t matter if sup...MillPub | SponsoredRUTHLESS Musk Move >> coming June 1?Elon Musk has made headlines with everything from mass layoffs to political drama — but his next move could sh...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Precipio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Precipio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.